{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:21:15Z","timestamp":1780078875713,"version":"3.54.0"},"reference-count":180,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94053-7","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:36:56Z","timestamp":1743122216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exploring new drug treatment targets for immune related bone diseases using a multi omics joint analysis strategy"],"prefix":"10.1038","volume":"15","author":[{"given":"Wei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"issue":"5","key":"94053_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.autrev.2008.12.019","volume":"8","author":"H Waldner","year":"2009","unstructured":"Waldner, H. The role of innate immune responses in autoimmune disease development. Autoimmun. Rev. 8(5), 400\u2013404. https:\/\/doi.org\/10.1016\/j.autrev.2008.12.019 (2009).","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"94053_CR2","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross, M. et al. The global burden of rheumatoid arthritis: Estimates from the global burden of disease 2010 study. Ann. Rheum. Dis. 73(7), 1316\u20131322. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204627 (2014).","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"94053_CR3","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/art.27425","volume":"62","author":"E Myasoedova","year":"2010","unstructured":"Myasoedova, E., Crowson, C. S., Kremers, H. M., Therneau, T. M. & Gabriel, S. E. Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955\u20132007. Arthritis Rheum. 62(6), 1576\u20131582. https:\/\/doi.org\/10.1002\/art.27425 (2010).","journal-title":"Arthritis Rheum."},{"issue":"9","key":"94053_CR4","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00296-017-3726-1","volume":"37","author":"TM Hunter","year":"2017","unstructured":"Hunter, T. M. et al. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004\u20132014. Rheumatol. Int. 37(9), 1551\u20131557. https:\/\/doi.org\/10.1007\/s00296-017-3726-1 (2017).","journal-title":"Rheumatol. Int."},{"issue":"10","key":"94053_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41584-022-00827-y","volume":"18","author":"A Finckh","year":"2022","unstructured":"Finckh, A. et al. Global epidemiology of rheumatoid arthritis. Nat. Rev. Rheumatol. 18(10), 591\u2013602. https:\/\/doi.org\/10.1038\/s41584-022-00827-y (2022).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10258","key":"94053_CR6","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/s0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos, T. et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 396(10258), 1204\u20131222. https:\/\/doi.org\/10.1016\/s0140-6736(20)30925-9 (2020).","journal-title":"Lancet."},{"issue":"5","key":"94053_CR7","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s40744-024-00709-7","volume":"11","author":"A Zabotti","year":"2024","unstructured":"Zabotti, A. et al. The challenge of IBD-related arthritis screening questionnaires in early and predominantly entheseal phenotypes. Rheumatol. Ther. 11(5), 1321\u20131331. https:\/\/doi.org\/10.1007\/s40744-024-00709-7 (2024).","journal-title":"Rheumatol. Ther."},{"issue":"10","key":"94053_CR8","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1007\/s10067-021-05713-8","volume":"40","author":"JF Merola","year":"2021","unstructured":"Merola, J. F. et al. Healthcare utilization and costs among patients with psoriasis and psoriatic arthritis in the USA-a retrospective study of claims data from 2009 to 2020. Clin. Rheumatol. 40(10), 4061\u20134070. https:\/\/doi.org\/10.1007\/s10067-021-05713-8 (2021).","journal-title":"Clin. Rheumatol."},{"issue":"3","key":"94053_CR9","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/1756-185x.13777","volume":"23","author":"YH Kwan","year":"2020","unstructured":"Kwan, Y. H. et al. The direct and indirect costs of axial spondyloarthritis (axSpA) in Singapore. Int. J. Rheum. Dis. 23(3), 334\u2013341. https:\/\/doi.org\/10.1111\/1756-185x.13777 (2020).","journal-title":"Int. J. Rheum. Dis."},{"key":"94053_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60091409","author":"A Gogulescu","year":"2024","unstructured":"Gogulescu, A. et al. Neurological side effects of TNF-\u03b1 inhibitors revisited: A review of case reports. Medicina (Kaunas) https:\/\/doi.org\/10.3390\/medicina60091409 (2024).","journal-title":"Medicina (Kaunas)"},{"issue":"4","key":"94053_CR11","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s40744-024-00674-1","volume":"11","author":"MW So","year":"2024","unstructured":"So, M. W., Kim, A. R. & Lee, S. G. Drug persistence and incidence of active tuberculosis of tumor necrosis factor alpha inhibitors versus tocilizumab as the first-line biological treatment in patients with rheumatoid arthritis: A nationwide population-based retrospective cohort analysis. Rheumatol. Ther. 11(4), 881\u2013895. https:\/\/doi.org\/10.1007\/s40744-024-00674-1 (2024).","journal-title":"Rheumatol. Ther."},{"issue":"414","key":"94053_CR12","first-page":"187","volume":"10","author":"PA Varisco","year":"2014","unstructured":"Varisco, P. A. & So, A. A new therapeutical option for chronic inflammation in rheumatology: Janus kinases inhibitors (JAK). Rev. Med. Suisse. 10(414), 187\u2013191 (2014).","journal-title":"Rev. Med. Suisse."},{"key":"94053_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae444","author":"I Hennessee","year":"2024","unstructured":"Hennessee, I., Benedict, K., Bahr, N. C., Lipner, S. R. & Gold, J. A. W. Incidence and risk factors for invasive fungal infections in patients initiating TNF-alpha inhibitors for inflammatory bowel disease and rheumatoid arthritis. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciae444 (2024).","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"94053_CR14","doi-asserted-by":"publisher","first-page":"CD011381","DOI":"10.1002\/14651858.CD011381.pub2","volume":"2015","author":"I Tramacere","year":"2015","unstructured":"Tramacere, I., Del Giovane, C., Salanti, G., D\u2019Amico, R. & Filippini, G. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis. Cochrane Database Syst. Rev. 2015(9), CD011381. https:\/\/doi.org\/10.1002\/14651858.CD011381.pub2 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"94053_CR15","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 53(12), 1712\u20131721. https:\/\/doi.org\/10.1038\/s41588-021-00978-w (2021).","journal-title":"Nat. Genet."},{"issue":"7982","key":"94053_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 622(7982), 329\u2013338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6 (2023).","journal-title":"Nature."},{"issue":"10","key":"94053_CR17","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue, S. et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat. Genet. 53(10), 1415\u20131424. https:\/\/doi.org\/10.1038\/s41588-021-00931-x (2021).","journal-title":"Nat. Genet."},{"key":"94053_CR18","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies, N. M., Holmes, M. V. & Davey, S. G. Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians. Bmj. 362, k601. https:\/\/doi.org\/10.1136\/bmj.k601 (2018).","journal-title":"Bmj."},{"issue":"11","key":"94053_CR19","doi-asserted-by":"publisher","first-page":"e1009922","DOI":"10.1371\/journal.pgen.1009922","volume":"17","author":"Z Lin","year":"2021","unstructured":"Lin, Z., Deng, Y. & Pan, W. Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model. PLoS Genet. 17(11), e1009922. https:\/\/doi.org\/10.1371\/journal.pgen.1009922 (2021).","journal-title":"PLoS Genet."},{"issue":"3","key":"94053_CR20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess, S. & Thompson, S. G. Avoiding bias from weak instruments in Mendelian randomization studies. Int. J. Epidemiol. 40(3), 755\u2013764. https:\/\/doi.org\/10.1093\/ije\/dyr036 (2011).","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"94053_CR21","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1186\/s12859-021-04531-8","volume":"22","author":"SH Lin","year":"2021","unstructured":"Lin, S. H., Thakur, R. & Machiela, M. J. LDexpress: An online tool for integrating population-specific linkage disequilibrium patterns with tissue-specific expression data. BMC Bioinform. 22(1), 608. https:\/\/doi.org\/10.1186\/s12859-021-04531-8 (2021).","journal-title":"BMC Bioinform."},{"key":"94053_CR22","doi-asserted-by":"publisher","first-page":"1453147","DOI":"10.3389\/fnut.2024.1453147","volume":"11","author":"X Li","year":"2024","unstructured":"Li, X., Xie, Z., Qiu, H., Xie, X. & Liu, L. Exploring the causal associations between diet-derived circulating antioxidants and the risk of endometriosis: A Mendelian randomization study. Front. Nutr. 11, 1453147. https:\/\/doi.org\/10.3389\/fnut.2024.1453147 (2024).","journal-title":"Front. Nutr."},{"issue":"7","key":"94053_CR23","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37(7), 658\u2013665. https:\/\/doi.org\/10.1002\/gepi.21758 (2013).","journal-title":"Genet. Epidemiol."},{"issue":"1","key":"94053_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/js9.0000000000001926","volume":"111","author":"L Zhou","year":"2024","unstructured":"Zhou, L. et al. Metabolic syndrome and cancer risk: A two-sample Mendelian randomization study of European ancestry. Int. J. Surg. 111(1), 311\u2013321. https:\/\/doi.org\/10.1097\/js9.0000000000001926 (2024).","journal-title":"Int. J. Surg."},{"issue":"5","key":"94053_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48(5), 481\u2013487. https:\/\/doi.org\/10.1038\/ng.3538 (2016).","journal-title":"Nat. Genet."},{"issue":"11","key":"94053_CR26","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.3406","volume":"47","author":"B Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47(11), 1236\u20131241. https:\/\/doi.org\/10.1038\/ng.3406 (2015).","journal-title":"Nat. Genet."},{"issue":"1","key":"94053_CR27","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1038\/s41467-022-32219-x","volume":"13","author":"CM Francis","year":"2022","unstructured":"Francis, C. M. et al. Genome-wide associations of aortic distensibility suggest causality for aortic aneurysms and brain white matter hyperintensities. Nat. Commun. 13(1), 4505. https:\/\/doi.org\/10.1038\/s41467-022-32219-x (2022).","journal-title":"Nat. Commun."},{"issue":"6220","key":"94053_CR28","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Proteomics. Tissue-based map of the human proteome. Science. 347(6220), 1260419. https:\/\/doi.org\/10.1126\/science.1260419 (2015).","journal-title":"Science."},{"issue":"D1","key":"94053_CR29","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic. Acids Res. 51(D1), D638\u2013D646. https:\/\/doi.org\/10.1093\/nar\/gkac1000 (2023).","journal-title":"Nucleic. Acids Res."},{"key":"94053_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biosystems.2014.11.005","volume":"127","author":"Y Tang","year":"2015","unstructured":"Tang, Y., Li, M., Wang, J., Pan, Y. & Wu, F. X. CytoNCA: A cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 127, 67\u201372. https:\/\/doi.org\/10.1016\/j.biosystems.2014.11.005 (2015).","journal-title":"Biosystems."},{"issue":"D1","key":"94053_CR31","doi-asserted-by":"publisher","first-page":"D331","DOI":"10.1093\/nar\/gkw1108","volume":"45","author":"SE Carbon","year":"2017","unstructured":"Carbon, S. E. et al. Expansion of the Gene Ontology knowledgebase and resources. Nucleic. Acids Res. 45(D1), D331\u2013D338. https:\/\/doi.org\/10.1093\/nar\/gkw1108 (2017).","journal-title":"Nucleic. Acids Res."},{"issue":"18","key":"94053_CR32","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo, M. et al. DSigDB: Drug signatures database for gene set analysis. Bioinformatics. 31(18), 3069\u20133071. https:\/\/doi.org\/10.1093\/bioinformatics\/btv313 (2015).","journal-title":"Bioinformatics."},{"issue":"1","key":"94053_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1182\/blood-2015-10-679191","volume":"128","author":"E Kotsiou","year":"2016","unstructured":"Kotsiou, E. et al. TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses. Blood. 128(1), 72\u201381. https:\/\/doi.org\/10.1182\/blood-2015-10-679191 (2016).","journal-title":"Blood."},{"issue":"1","key":"94053_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1600-065X.2011.01064.x","volume":"244","author":"MW Steinberg","year":"2011","unstructured":"Steinberg, M. W., Cheung, T. C. & Ware, C. F. The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation. Immunol. Rev. 244(1), 169\u2013187. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01064.x (2011).","journal-title":"Immunol. Rev."},{"issue":"Pt A","key":"94053_CR35","doi-asserted-by":"publisher","first-page":"113056","DOI":"10.1016\/j.intimp.2024.113056","volume":"142","author":"JW Chang","year":"2024","unstructured":"Chang, J. W. & Tang, C. H. The role of macrophage polarization in rheumatoid arthritis and osteoarthritis: Pathogenesis and therapeutic strategies. Int. Immunopharmacol. 142(Pt A), 113056. https:\/\/doi.org\/10.1016\/j.intimp.2024.113056 (2024).","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"94053_CR36","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1007\/s10753-011-9417-2","volume":"35","author":"Y Shang","year":"2012","unstructured":"Shang, Y. et al. The expression and anatomical distribution of BTLA and its ligand HVEM in rheumatoid synovium. Inflammation. 35(3), 1102\u20131112. https:\/\/doi.org\/10.1007\/s10753-011-9417-2 (2012).","journal-title":"Inflammation."},{"issue":"3","key":"94053_CR37","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ajhg.2012.01.010","volume":"90","author":"FA Kurreeman","year":"2012","unstructured":"Kurreeman, F. A. et al. Use of a multiethnic approach to identify rheumatoid- arthritis-susceptibility loci, 1p36 and 17q12. Am. J. Hum. Genet. 90(3), 524\u2013532. https:\/\/doi.org\/10.1016\/j.ajhg.2012.01.010 (2012).","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"94053_CR38","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.smim.2009.04.002","volume":"21","author":"Y Li","year":"2009","unstructured":"Li, Y. & Begovich, A. B. Unraveling the genetics of complex diseases: Susceptibility genes for rheumatoid arthritis and psoriasis. Semin. Immunol. 21(6), 318\u2013327. https:\/\/doi.org\/10.1016\/j.smim.2009.04.002 (2009).","journal-title":"Semin. Immunol."},{"issue":"2","key":"94053_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/gene.2010.42","volume":"12","author":"F Blanco-Kelly","year":"2011","unstructured":"Blanco-Kelly, F. et al. Members 6B and 14 of the TNF receptor superfamily in multiple sclerosis predisposition. Genes Immun. 12(2), 145\u2013148. https:\/\/doi.org\/10.1038\/gene.2010.42 (2011).","journal-title":"Genes Immun."},{"key":"94053_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2022.07.006","volume":"268\u2013269","author":"AK Yenamandra","year":"2022","unstructured":"Yenamandra, A. K. et al. Evidence-based review of genomic aberrations in diffuse large B cell lymphoma, not otherwise specified (DLBCL, NOS): Report from the cancer genomics consortium lymphoma working group. Cancer Genet. 268\u2013269, 1\u201321. https:\/\/doi.org\/10.1016\/j.cancergen.2022.07.006 (2022).","journal-title":"Cancer Genet."},{"issue":"2","key":"94053_CR41","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1365-2567.2004.02004.x","volume":"114","author":"WJ Kim","year":"2005","unstructured":"Kim, W. J. et al. LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages. Immunology. 114(2), 272\u2013279. https:\/\/doi.org\/10.1111\/j.1365-2567.2004.02004.x (2005).","journal-title":"Immunology."},{"issue":"4 Suppl 55","key":"94053_CR42","first-page":"S20","volume":"27","author":"WP Maksymowych","year":"2009","unstructured":"Maksymowych, W. P. & Brown, M. A. Genetics of ankylosing spondylitis and rheumatoid arthritis: Where are we at currently, and how do they compare?. Clin. Exp. Rheumatol. 27(4 Suppl 55), S20\u2013S25 (2009).","journal-title":"Clin. Exp. Rheumatol."},{"key":"94053_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2172-14-32","volume":"14","author":"M Jern\u00e5s","year":"2013","unstructured":"Jern\u00e5s, M. et al. MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS). BMC Immunol. 14, 32. https:\/\/doi.org\/10.1186\/1471-2172-14-32 (2013).","journal-title":"BMC Immunol."},{"issue":"5","key":"94053_CR44","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.immuni.2016.04.019","volume":"44","author":"LK Ward-Kavanagh","year":"2016","unstructured":"Ward-Kavanagh, L. K., Lin, W. W., \u0160ed\u00fd, J. R. & Ware, C. F. The TNF receptor superfamily in Co-stimulating and Co-inhibitory responses. Immunity. 44(5), 1005\u20131019. https:\/\/doi.org\/10.1016\/j.immuni.2016.04.019 (2016).","journal-title":"Immunity."},{"key":"94053_CR45","doi-asserted-by":"publisher","first-page":"111785","DOI":"10.1016\/j.biopha.2021.111785","volume":"140","author":"S Patel","year":"2021","unstructured":"Patel, S. & Wadhwa, M. Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19. Biomed. Pharmacother. 140, 111785. https:\/\/doi.org\/10.1016\/j.biopha.2021.111785 (2021).","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"94053_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/1940-6207.Capr-20-0360","volume":"14","author":"TH Nasti","year":"2021","unstructured":"Nasti, T. H. et al. Regulatory T cells play an important role in the prevention of murine melanocytic nevi and melanomas. Cancer Prev. Res. (Phila). 14(2), 165\u2013174. https:\/\/doi.org\/10.1158\/1940-6207.Capr-20-0360 (2021).","journal-title":"Cancer Prev. Res. (Phila)."},{"issue":"1","key":"94053_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/toxsci\/kfi176","volume":"86","author":"J Gao","year":"2005","unstructured":"Gao, J., Lauer, F. T., Dunaway, S. & Burchiel, S. W. Cytochrome P450 1B1 is required for 7,12-dimethylbenz(a)-anthracene (DMBA) induced spleen cell immunotoxicity. Toxicol. Sci. 86(1), 68\u201374. https:\/\/doi.org\/10.1093\/toxsci\/kfi176 (2005).","journal-title":"Toxicol. Sci."},{"issue":"1","key":"94053_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0041-008x(91)90287-o","volume":"110","author":"GS Ladics","year":"1991","unstructured":"Ladics, G. S., Kawabata, T. T. & White, K. L. Jr. Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz[a]anthracene metabolites and inhibition of immunosuppression by alpha-naphthoflavone. Toxicol. Appl. Pharmacol. 110(1), 31\u201344. https:\/\/doi.org\/10.1016\/0041-008x(91)90287-o (1991).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"94053_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/imr.12799","volume":"292","author":"V Saxena","year":"2019","unstructured":"Saxena, V. et al. Role of lymph node stroma and microenvironment in T cell tolerance. Immunol. Rev. 292(1), 9\u201323. https:\/\/doi.org\/10.1111\/imr.12799 (2019).","journal-title":"Immunol. Rev."},{"issue":"3","key":"94053_CR50","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1158\/2326-6066.Cir-19-0574","volume":"8","author":"H Kagamu","year":"2020","unstructured":"Kagamu, H. et al. CD4(+) T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy. Cancer Immunol. Res. 8(3), 334\u2013344. https:\/\/doi.org\/10.1158\/2326-6066.Cir-19-0574 (2020).","journal-title":"Cancer Immunol. Res."},{"issue":"9","key":"94053_CR51","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1002\/art.38023","volume":"65","author":"J Sellam","year":"2013","unstructured":"Sellam, J. et al. CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis. Arthritis Rheum. 65(9), 2253\u20132261. https:\/\/doi.org\/10.1002\/art.38023 (2013).","journal-title":"Arthritis Rheum."},{"issue":"2","key":"94053_CR52","first-page":"272","volume":"46","author":"LJ Shi","year":"2015","unstructured":"Shi, L. J. et al. CCL19\/IL-1beta positive feedback loop involved in the progress of inflammation in rheumatoid arthritis. Sichuan Da Xue Xue Bao Yi Xue Ban. 46(2), 272\u2013275 (2015).","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban."},{"issue":"1","key":"94053_CR53","doi-asserted-by":"publisher","first-page":"14386","DOI":"10.1038\/s41598-020-71362-7","volume":"10","author":"X Guo","year":"2020","unstructured":"Guo, X. et al. Accumulation of synovial fluid CD19(+)CD24(hi)CD27(+) B cells was associated with bone destruction in rheumatoid arthritis. Sci. Rep. 10(1), 14386. https:\/\/doi.org\/10.1038\/s41598-020-71362-7 (2020).","journal-title":"Sci. Rep."},{"issue":"1","key":"94053_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13075-018-1529-8","volume":"20","author":"JS H\u00e4hnlein","year":"2018","unstructured":"H\u00e4hnlein, J. S. et al. Impaired lymph node stromal cell function during the earliest phases of rheumatoid arthritis. Arthritis Res. Ther. 20(1), 35. https:\/\/doi.org\/10.1186\/s13075-018-1529-8 (2018).","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"94053_CR55","first-page":"667","volume":"48","author":"LJ Shi","year":"2016","unstructured":"Shi, L. J. et al. Clinical significance of serum C-C chemokine ligand 19 levels in patients with rheumatoid arthritis. Beijing Da Xue Xue Bao Yi Xue Ban. 48(4), 667\u2013671 (2016).","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban."},{"issue":"21","key":"94053_CR56","doi-asserted-by":"publisher","first-page":"12369","DOI":"10.18632\/aging.205184","volume":"15","author":"Q Gu","year":"2023","unstructured":"Gu, Q. et al. CCL19: A novel prognostic chemokine modulates the tumor immune microenvironment and outcomes of cancers. Aging (Albany NY). 15(21), 12369\u201312387. https:\/\/doi.org\/10.18632\/aging.205184 (2023).","journal-title":"Aging (Albany NY)."},{"key":"94053_CR57","doi-asserted-by":"publisher","first-page":"830437","DOI":"10.3389\/fgene.2022.830437","volume":"13","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. Identification of CCL19 as a novel immune-related biomarker in diabetic nephropathy. Front. Genet. 13, 830437. https:\/\/doi.org\/10.3389\/fgene.2022.830437 (2022).","journal-title":"Front. Genet."},{"key":"94053_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/cells11091444","author":"OJ Gerken","year":"2022","unstructured":"Gerken, O. J., Artinger, M. & Legler, D. F. Shifting CCR7 towards Its Monomeric Form Augments CCL19 Binding and Uptake. Cells https:\/\/doi.org\/10.3390\/cells11091444 (2022).","journal-title":"Cells"},{"key":"94053_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/itt.S243636","volume":"9","author":"NM Elemam","year":"2020","unstructured":"Elemam, N. M., Hannawi, S. & Maghazachi, A. A. Role of chemokines and chemokine receptors in rheumatoid arthritis. Immunotargets Ther. 9, 43\u201356. https:\/\/doi.org\/10.2147\/itt.S243636 (2020).","journal-title":"Immunotargets Ther."},{"issue":"12","key":"94053_CR60","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1021\/tx900241g","volume":"22","author":"WC Chu","year":"2009","unstructured":"Chu, W. C. et al. 1-Nitropyrene stabilizes the mRNA of cytochrome P450 1a1, a carcinogen-metabolizing enzyme, via the Akt pathway. Chem. Res. Toxicol. 22(12), 1938\u20131947. https:\/\/doi.org\/10.1021\/tx900241g (2009).","journal-title":"Chem. Res. Toxicol."},{"key":"94053_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/toxics9110276","author":"PK Tsai","year":"2021","unstructured":"Tsai, P. K. et al. Proinflammatory responses of 1-Nitropyrene against RAW264.7 Macrophages through Akt Phosphorylation and NF-\u03baB pathways. Toxics https:\/\/doi.org\/10.3390\/toxics9110276 (2021).","journal-title":"Toxics"},{"key":"94053_CR62","doi-asserted-by":"publisher","first-page":"133704","DOI":"10.1016\/j.jhazmat.2024.133704","volume":"468","author":"SR Li","year":"2024","unstructured":"Li, S. R. et al. ALKBH5 SUMOylation-mediated FBXW7 m6A modification regulates alveolar cells senescence during 1-nitropyrene-induced pulmonary fibrosis. J. Hazard Mater. 468, 133704. https:\/\/doi.org\/10.1016\/j.jhazmat.2024.133704 (2024).","journal-title":"J. Hazard Mater."},{"issue":"2","key":"94053_CR63","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jprot.2011.08.021","volume":"75","author":"J Zhao","year":"2011","unstructured":"Zhao, J. et al. Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF). J. Proteomics. 75(2), 588\u2013602. https:\/\/doi.org\/10.1016\/j.jprot.2011.08.021 (2011).","journal-title":"J. Proteomics."},{"issue":"7","key":"94053_CR64","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1002\/dvdy.21589","volume":"237","author":"R Gallitzendoerfer","year":"2008","unstructured":"Gallitzendoerfer, R. et al. Hepatoma-derived growth factor (HDGF) is dispensable for normal mouse development. Dev. Dyn. 237(7), 1875\u20131885. https:\/\/doi.org\/10.1002\/dvdy.21589 (2008).","journal-title":"Dev. Dyn."},{"key":"94053_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124216","author":"H Enomoto","year":"2020","unstructured":"Enomoto, H., Nakamura, H., Nishikawa, H., Nishiguchi, S. & Iijima, H. Hepatoma-derived growth factor: An overview and its role as a potential therapeutic target molecule for digestive malignancies. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21124216 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"94053_CR66","doi-asserted-by":"publisher","first-page":"105335","DOI":"10.1016\/j.jbc.2023.105335","volume":"299","author":"TH Hu","year":"2023","unstructured":"Hu, T. H. et al. HDGF stimulates liver tumorigenesis by enhancing reactive oxygen species generation in mitochondria. J. Biol. Chem. 299(11), 105335. https:\/\/doi.org\/10.1016\/j.jbc.2023.105335 (2023).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"94053_CR67","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41420-023-01476-0","volume":"9","author":"S Han","year":"2023","unstructured":"Han, S. et al. HDGF promotes gefitinib resistance by activating the PI3K\/AKT and MEK\/ERK signaling pathways in non-small cell lung cancer. Cell Death Discov. 9(1), 181. https:\/\/doi.org\/10.1038\/s41420-023-01476-0 (2023).","journal-title":"Cell Death Discov."},{"key":"94053_CR68","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ijbiomac.2019.01.121","volume":"128","author":"Y Zheng","year":"2019","unstructured":"Zheng, Y., Lu, S., Xu, Y. & Zheng, J. Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a\/b-5p to upregulate the expression of HDGF and activating Wnt\/\u03b2-catenin signaling pathway. Int. J. Biol. Macromol. 128, 521\u2013530. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.01.121 (2019).","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"94053_CR69","doi-asserted-by":"publisher","first-page":"192","DOI":"10.18632\/aging.100296","volume":"3","author":"LS Steelman","year":"2011","unstructured":"Steelman, L. S. et al. Roles of the Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging (Albany NY). 3(3), 192\u2013222. https:\/\/doi.org\/10.18632\/aging.100296 (2011).","journal-title":"Aging (Albany NY)."},{"issue":"10","key":"94053_CR70","doi-asserted-by":"publisher","first-page":"20443","DOI":"10.3390\/ijms141020443","volume":"14","author":"TR Su","year":"2013","unstructured":"Su, T. R. et al. Inhibition of melanogenesis by gallic acid: Possible involvement of the PI3K\/Akt, MEK\/ERK and Wnt\/\u03b2-catenin signaling pathways in B16F10 cells. Int. J. Mol. Sci. 14(10), 20443\u201320458. https:\/\/doi.org\/10.3390\/ijms141020443 (2013).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"94053_CR71","doi-asserted-by":"publisher","first-page":"e24474","DOI":"10.1002\/jcla.24474","volume":"36","author":"SS Ahn","year":"2022","unstructured":"Ahn, S. S., Kim, H. M. & Park, Y. Association of serum hepatoma-derived growth factor levels with disease activity in rheumatoid arthritis: A pilot study. J. Clin. Lab. Anal. 36(6), e24474. https:\/\/doi.org\/10.1002\/jcla.24474 (2022).","journal-title":"J. Clin. Lab. Anal."},{"issue":"12","key":"94053_CR72","doi-asserted-by":"publisher","first-page":"16163","DOI":"10.1096\/fj.202000511RR","volume":"34","author":"EM Wang","year":"2020","unstructured":"Wang, E. M. et al. Hepatoma-derived growth factor participates in concanavalin A-induced hepatitis. Faseb. j. 34(12), 16163\u201316178. https:\/\/doi.org\/10.1096\/fj.202000511RR (2020).","journal-title":"Faseb. j."},{"issue":"5","key":"94053_CR73","doi-asserted-by":"publisher","first-page":"zqab037","DOI":"10.1093\/function\/zqab037","volume":"2","author":"SJ Keppie","year":"2021","unstructured":"Keppie, S. J. et al. Matrix-bound growth factors are released upon cartilage compression by an aggrecan-dependent sodium flux that is lost in osteoarthritis. Function (Oxf). 2(5), zqab037. https:\/\/doi.org\/10.1093\/function\/zqab037 (2021).","journal-title":"Function (Oxf)."},{"issue":"1","key":"94053_CR74","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1186\/s12935-020-01560-w","volume":"20","author":"C Zhou","year":"2020","unstructured":"Zhou, C., Li, C., Yan, F. & Zheng, Y. Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma. Cancer Cell Int. 20(1), 541. https:\/\/doi.org\/10.1186\/s12935-020-01560-w (2020).","journal-title":"Cancer Cell Int."},{"issue":"1","key":"94053_CR75","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cyto.2014.12.001","volume":"72","author":"AM Sun","year":"2015","unstructured":"Sun, A. M. et al. Hepatocarcinoma cell-derived hepatoma-derived growth factor (HDGF) induces regulatory T cells. Cytokine. 72(1), 31\u201335. https:\/\/doi.org\/10.1016\/j.cyto.2014.12.001 (2015).","journal-title":"Cytokine."},{"key":"94053_CR76","doi-asserted-by":"publisher","first-page":"1161476","DOI":"10.3389\/fimmu.2023.1161476","volume":"14","author":"L Zeng","year":"2023","unstructured":"Zeng, L. et al. Potential common molecular mechanisms between Sj\u00f6gren syndrome and inclusion body myositis: A bioinformatic analysis and in vivo validation. Front. Immunol. 14, 1161476. https:\/\/doi.org\/10.3389\/fimmu.2023.1161476 (2023).","journal-title":"Front. Immunol."},{"issue":"24","key":"94053_CR77","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1001\/jama.2011.878","volume":"305","author":"DH Solomon","year":"2011","unstructured":"Solomon, D. H. et al. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. Jama. 305(24), 2525\u20132531. https:\/\/doi.org\/10.1001\/jama.2011.878 (2011).","journal-title":"Jama."},{"issue":"2","key":"94053_CR78","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1172\/jci9652","volume":"106","author":"Y Kawahito","year":"2000","unstructured":"Kawahito, Y. et al. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J. Clin. Invest. 106(2), 189\u2013197. https:\/\/doi.org\/10.1172\/jci9652 (2000).","journal-title":"J. Clin. Invest."},{"issue":"2","key":"94053_CR79","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1365-2249.2002.01876.x","volume":"129","author":"S Yamasaki","year":"2002","unstructured":"Yamasaki, S. et al. Functional changes in rheumatoid fibroblast-like synovial cells through activation of peroxisome proliferator-activated receptor gamma-mediated signalling pathway. Clin. Exp. Immunol. 129(2), 379\u2013384. https:\/\/doi.org\/10.1046\/j.1365-2249.2002.01876.x (2002).","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"94053_CR80","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/ar4146","volume":"15","author":"JE Gibbs","year":"2013","unstructured":"Gibbs, J. E. & Ray, D. W. The role of the circadian clock in rheumatoid arthritis. Arthritis Res. Ther. 15(1), 205. https:\/\/doi.org\/10.1186\/ar4146 (2013).","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"94053_CR81","doi-asserted-by":"publisher","first-page":"e13804","DOI":"10.1111\/ijcp.13804","volume":"75","author":"MS Hsieh","year":"2021","unstructured":"Hsieh, M. S., Hung, P. S., Hsieh, V. C., Liao, S. H. & How, C. K. Association between thiazolidinedione use and rheumatoid arthritis risk in patients with type II diabetes, a population-based, case-control study. Int. J. Clin. Pract. 75(3), e13804. https:\/\/doi.org\/10.1111\/ijcp.13804 (2021).","journal-title":"Int. J. Clin. Pract."},{"issue":"4","key":"94053_CR82","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/liv.13265","volume":"37","author":"S Restellini","year":"2017","unstructured":"Restellini, S., Chazouill\u00e8res, O. & Frossard, J. L. Hepatic manifestations of inflammatory bowel diseases. Liver Int. 37(4), 475\u2013489. https:\/\/doi.org\/10.1111\/liv.13265 (2017).","journal-title":"Liver Int."},{"key":"94053_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13071869","author":"A Shafrir","year":"2024","unstructured":"Shafrir, A. et al. Low ALT Is associated with IBD and disease activity: Results from a nationwide study. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm13071869 (2024).","journal-title":"J. Clin. Med."},{"key":"94053_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/nu16081174","author":"ACS Rabelo","year":"2024","unstructured":"Rabelo, A. C. S., Andrade, A. K. L. & Costa, D. C. The role of oxidative stress in alcoholic fatty liver disease: A systematic review and meta-analysis of preclinical studies. Nutrients https:\/\/doi.org\/10.3390\/nu16081174 (2024).","journal-title":"Nutrients"},{"issue":"13","key":"94053_CR85","doi-asserted-by":"publisher","first-page":"e33418","DOI":"10.1016\/j.heliyon.2024.e33418","volume":"10","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. Metabolomics analyses reveal the liver-protective mechanism of Wang\u2019s metabolic formula on metabolic-associated fatty liver disease. Heliyon. 10(13), e33418. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33418 (2024).","journal-title":"Heliyon."},{"issue":"15\u201316","key":"94053_CR86","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/scd.2024.0067","volume":"33","author":"Z Zhou","year":"2024","unstructured":"Zhou, Z. et al. Mice hepatic organoids for modeling nonalcoholic fatty liver disease and drug response. Stem. Cells Dev. 33(15\u201316), 387\u2013398. https:\/\/doi.org\/10.1089\/scd.2024.0067 (2024).","journal-title":"Stem. Cells Dev."},{"issue":"8","key":"94053_CR87","doi-asserted-by":"publisher","first-page":"167489","DOI":"10.1016\/j.bbadis.2024.167489","volume":"1870","author":"C Bauset","year":"2024","unstructured":"Bauset, C. et al. A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD patients: Potential role of GPR109A in macrophages. Biochim. Biophys. Acta Mol. Basis. Dis. 1870(8), 167489. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167489 (2024).","journal-title":"Biochim. Biophys. Acta Mol. Basis. Dis."},{"issue":"11","key":"94053_CR88","doi-asserted-by":"publisher","first-page":"e70075","DOI":"10.1002\/ctm2.70075","volume":"14","author":"L Clua-Ferr\u00e9","year":"2024","unstructured":"Clua-Ferr\u00e9, L. et al. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles: A focus on inflammatory bowel disease. Clin. Transl. Med. 14(11), e70075. https:\/\/doi.org\/10.1002\/ctm2.70075 (2024).","journal-title":"Clin. Transl. Med."},{"issue":"2","key":"94053_CR89","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12519-019-00235-5","volume":"15","author":"M Cakir","year":"2019","unstructured":"Cakir, M., Sag, E., Dogan, G., Unal, F. & Kasirga, E. Clinical significance of low transaminase levels in children with inflammatory bowel disease. World J. Pediatr. 15(2), 143\u2013147. https:\/\/doi.org\/10.1007\/s12519-019-00235-5 (2019).","journal-title":"World J. Pediatr."},{"issue":"6","key":"94053_CR90","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1080\/00365520410005162","volume":"39","author":"S Vadstrup","year":"2004","unstructured":"Vadstrup, S. Subnormal alanine aminotransferase values in blood of patients with Crohn disease. Scand J. Gastroenterol. 39(6), 554\u2013556. https:\/\/doi.org\/10.1080\/00365520410005162 (2004).","journal-title":"Scand J. Gastroenterol."},{"issue":"9","key":"94053_CR91","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1111\/jgh.16619","volume":"39","author":"LY Wang","year":"2024","unstructured":"Wang, L. Y., He, L. H., Xu, L. J. & Li, S. B. Short-chain fatty acids: Bridges between diet, gut microbiota, and health. J. Gastroenterol. Hepatol. 39(9), 1728\u20131736. https:\/\/doi.org\/10.1111\/jgh.16619 (2024).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"94053_CR92","doi-asserted-by":"publisher","first-page":"114713","DOI":"10.1016\/j.jep.2021.114713","volume":"283","author":"JS Li","year":"2022","unstructured":"Li, J. S. et al. Mulberry leaves ameliorate diabetes via regulating metabolic profiling and AGEs\/RAGE and p38 MAPK\/NF-\u03baB pathway. J. Ethnopharmacol. 283, 114713. https:\/\/doi.org\/10.1016\/j.jep.2021.114713 (2022).","journal-title":"J. Ethnopharmacol."},{"key":"94053_CR93","doi-asserted-by":"publisher","first-page":"118011","DOI":"10.1016\/j.jep.2024.118011","volume":"327","author":"W Jia","year":"2024","unstructured":"Jia, W. et al. Rujifang inhibits triple-negative breast cancer growth via the PI3K\/AKT pathway. J. Ethnopharmacol. 327, 118011. https:\/\/doi.org\/10.1016\/j.jep.2024.118011 (2024).","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"94053_CR94","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1189\/jlb.1012519","volume":"94","author":"K Kierdorf","year":"2013","unstructured":"Kierdorf, K. & Fritz, G. RAGE regulation and signaling in inflammation and beyond. J. Leukoc Biol. 94(1), 55\u201368. https:\/\/doi.org\/10.1189\/jlb.1012519 (2013).","journal-title":"J. Leukoc Biol."},{"issue":"5","key":"94053_CR95","doi-asserted-by":"publisher","first-page":"812","DOI":"10.37349\/etat.2023.00170","volume":"4","author":"G Palanissami","year":"2023","unstructured":"Palanissami, G. & Paul, S. F. D. AGEs and RAGE: Metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers. Explor. Target Antitumor. Ther. 4(5), 812\u2013849. https:\/\/doi.org\/10.37349\/etat.2023.00170 (2023).","journal-title":"Explor. Target Antitumor. Ther."},{"key":"94053_CR96","doi-asserted-by":"publisher","first-page":"931473","DOI":"10.3389\/fimmu.2022.931473","volume":"13","author":"H Dong","year":"2022","unstructured":"Dong, H., Zhang, Y., Huang, Y. & Deng, H. Pathophysiology of RAGE in inflammatory diseases. Front. Immunol. 13, 931473. https:\/\/doi.org\/10.3389\/fimmu.2022.931473 (2022).","journal-title":"Front. Immunol."},{"key":"94053_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010403","author":"W Li","year":"2025","unstructured":"Li, W. et al. Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer\u2019s Disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms26010403 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"94053_CR98","doi-asserted-by":"publisher","first-page":"106520","DOI":"10.1016\/j.intimp.2020.106520","volume":"84","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Physiological concentrations of bilirubin control inflammatory response by inhibiting NF-\u03baB and inflammasome activation. Int. Immunopharmacol. 84, 106520. https:\/\/doi.org\/10.1016\/j.intimp.2020.106520 (2020).","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"94053_CR99","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/bf02814488","volume":"36","author":"V V\u0115tvicka","year":"1991","unstructured":"V\u0115tvicka, V., S\u00edma, P., Miler, I. & Bilej, M. The immunosuppressive effects of bilirubin. Folia Microbiol. (Praha). 36(2), 112\u2013119. https:\/\/doi.org\/10.1007\/bf02814488 (1991).","journal-title":"Folia Microbiol. (Praha)."},{"issue":"1","key":"94053_CR100","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s40001-024-01963-9","volume":"29","author":"SS Huang","year":"2024","unstructured":"Huang, S. S. et al. Exploring the inverse relationship between serum total bilirubin and systemic immune-inflammation index: insights from NHANES data (2009\u20132018). Eur. J. Med. Res. 29(1), 362. https:\/\/doi.org\/10.1186\/s40001-024-01963-9 (2024).","journal-title":"Eur. J. Med. Res."},{"issue":"3","key":"94053_CR101","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.4049\/jimmunol.181.3.1887","volume":"181","author":"Y Liu","year":"2008","unstructured":"Liu, Y. et al. Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis. J. Immunol. 181(3), 1887\u20131897. https:\/\/doi.org\/10.4049\/jimmunol.181.3.1887 (2008).","journal-title":"J. Immunol."},{"issue":"1","key":"94053_CR102","doi-asserted-by":"publisher","first-page":"182","DOI":"10.14309\/ajg.0000000000003115","volume":"120","author":"N Verma","year":"2025","unstructured":"Verma, N. et al. Liver dysfunction and systemic inflammation drive organ failures in acute decompensation of cirrhosis: A multicentric study. Am. J. Gastroenterol. 120(1), 182\u2013193. https:\/\/doi.org\/10.14309\/ajg.0000000000003115 (2025).","journal-title":"Am. J. Gastroenterol."},{"issue":"9","key":"94053_CR103","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00109-017-1545-1","volume":"95","author":"MS Longhi","year":"2017","unstructured":"Longhi, M. S., Moss, A., Jiang, Z. G. & Robson, S. C. Purinergic signaling during intestinal inflammation. J. Mol. Med. (Berl). 95(9), 915\u2013925. https:\/\/doi.org\/10.1007\/s00109-017-1545-1 (2017).","journal-title":"J. Mol. Med. (Berl)."},{"issue":"11","key":"94053_CR104","doi-asserted-by":"publisher","first-page":"10996","DOI":"10.1021\/acsnano.3c03252","volume":"17","author":"AT Rahman","year":"2023","unstructured":"Rahman, A. T. et al. Bilirubin nanomedicine rescues intestinal barrier destruction and restores mucosal immunity in colitis. ACS Nano. 17(11), 10996\u201311013. https:\/\/doi.org\/10.1021\/acsnano.3c03252 (2023).","journal-title":"ACS Nano."},{"issue":"7","key":"94053_CR105","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.4049\/jimmunol.0900416","volume":"184","author":"IA Smith","year":"2010","unstructured":"Smith, I. A. et al. BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. J. Immunol. 184(7), 3514\u20133525. https:\/\/doi.org\/10.4049\/jimmunol.0900416 (2010).","journal-title":"J. Immunol."},{"key":"94053_CR106","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008303","author":"YS Kim","year":"2024","unstructured":"Kim, Y. S. et al. BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1. J. Immunother. Cancer https:\/\/doi.org\/10.1136\/jitc-2023-008303 (2024).","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"94053_CR107","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1186\/s12967-024-05467-2","volume":"22","author":"C Lund-Andersen","year":"2024","unstructured":"Lund-Andersen, C. et al. Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer. J. Transl. Med. 22(1), 646. https:\/\/doi.org\/10.1186\/s12967-024-05467-2 (2024).","journal-title":"J. Transl. Med."},{"issue":"2","key":"94053_CR108","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/iid3.105","volume":"4","author":"C Lebrero-Fern\u00e1ndez","year":"2016","unstructured":"Lebrero-Fern\u00e1ndez, C. et al. Altered expression of Butyrophilin (BTN) and BTN-like (BTNL) genes in intestinal inflammation and colon cancer. Immun. Inflamm. Dis. 4(2), 191\u2013200. https:\/\/doi.org\/10.1002\/iid3.105 (2016).","journal-title":"Immun. Inflamm. Dis."},{"key":"94053_CR109","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev-immunol-041015-055435","volume":"34","author":"DA Rhodes","year":"2016","unstructured":"Rhodes, D. A., Reith, W. & Trowsdale, J. Regulation of Immunity by Butyrophilins. Annu. Rev. Immunol. 34, 151\u2013172. https:\/\/doi.org\/10.1146\/annurev-immunol-041015-055435 (2016).","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"94053_CR110","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.it.2011.09.007","volume":"33","author":"L Abeler-D\u00f6rner","year":"2012","unstructured":"Abeler-D\u00f6rner, L., Swamy, M., Williams, G., Hayday, A. C. & Bas, A. Butyrophilins: An emerging family of immune regulators. Trends Immunol. 33(1), 34\u201341. https:\/\/doi.org\/10.1016\/j.it.2011.09.007 (2012).","journal-title":"Trends Immunol."},{"issue":"10","key":"94053_CR111","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1515\/hsz-2021-0122","volume":"402","author":"A Eichinger","year":"2021","unstructured":"Eichinger, A., Neumaier, I. & Skerra, A. The extracellular region of bovine milk butyrophilin exhibits closer structural similarity to human myelin oligodendrocyte glycoprotein than to immunological BTN family receptors. Biol. Chem. 402(10), 1187\u20131202. https:\/\/doi.org\/10.1515\/hsz-2021-0122 (2021).","journal-title":"Biol. Chem."},{"issue":"1","key":"94053_CR112","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000110295","volume":"12","author":"D Malosse","year":"1993","unstructured":"Malosse, D. & Perron, H. Correlation analysis between bovine populations, other farm animals, house pets, and multiple sclerosis prevalence. Neuroepidemiology 12(1), 15\u201327. https:\/\/doi.org\/10.1159\/000110295 (1993).","journal-title":"Neuroepidemiology"},{"issue":"2","key":"94053_CR113","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.intimp.2007.10.018","volume":"8","author":"M Fararjeh","year":"2008","unstructured":"Fararjeh, M., Mohammad, M. K., Bustanji, Y., Alkhatib, H. & Abdalla, S. Evaluation of immunosuppression induced by metronidazole in Balb\/c mice and human peripheral blood lymphocytes. Int. Immunopharmacol. 8(2), 341\u2013350. https:\/\/doi.org\/10.1016\/j.intimp.2007.10.018 (2008).","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"94053_CR114","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ccr3.1334","volume":"6","author":"J Lew","year":"2018","unstructured":"Lew, J. & Berenberg, J. Metronidazole caused profound drug-induced immune thrombocytopenia. Clin. Case Rep. 6(1), 206\u2013208. https:\/\/doi.org\/10.1002\/ccr3.1334 (2018).","journal-title":"Clin. Case Rep."},{"key":"94053_CR115","doi-asserted-by":"publisher","first-page":"117426","DOI":"10.1016\/j.jns.2021.117426","volume":"424","author":"JM Ferro","year":"2021","unstructured":"Ferro, J. M. & Oliveira, S. M. Neurology of inflammatory bowel disease. J. Neurol. Sci. 424, 117426. https:\/\/doi.org\/10.1016\/j.jns.2021.117426 (2021).","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"94053_CR116","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/gene.2008.22","volume":"9","author":"IA Hoppenbrouwers","year":"2008","unstructured":"Hoppenbrouwers, I. A. et al. EVI5 is a risk gene for multiple sclerosis. Genes Immun. 9(4), 334\u2013337. https:\/\/doi.org\/10.1038\/gene.2008.22 (2008).","journal-title":"Genes Immun."},{"issue":"12","key":"94053_CR117","doi-asserted-by":"publisher","first-page":"e26493","DOI":"10.1371\/journal.pone.0026493","volume":"6","author":"N Jafari","year":"2011","unstructured":"Jafari, N., Broer, L., van Duijn, C. M., Janssens, A. C. & Hintzen, R. Q. Perspectives on the use of multiple sclerosis risk genes for prediction. PLoS One. 6(12), e26493. https:\/\/doi.org\/10.1371\/journal.pone.0026493 (2011).","journal-title":"PLoS One."},{"issue":"1","key":"94053_CR118","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1038\/s41467-024-48165-9","volume":"15","author":"S Soltani","year":"2024","unstructured":"Soltani, S., Webb, S. M., Kroll, T. & King-Jones, K. Drosophila Evi5 is a critical regulator of intracellular iron transport via transferrin and ferritin interactions. Nat. Commun. 15(1), 4045. https:\/\/doi.org\/10.1038\/s41467-024-48165-9 (2024).","journal-title":"Nat. Commun."},{"issue":"1","key":"94053_CR119","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13046-020-01585-z","volume":"39","author":"T Cai","year":"2020","unstructured":"Cai, T. et al. EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells. J. Exp. Clin. Cancer Res. 39(1), 84. https:\/\/doi.org\/10.1186\/s13046-020-01585-z (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"94053_CR120","doi-asserted-by":"publisher","first-page":"7327","DOI":"10.1038\/s41598-020-64432-3","volume":"10","author":"M Dashti","year":"2020","unstructured":"Dashti, M., Ateyah, K., Alroughani, R. & Al-Temaimi, R. Replication analysis of variants associated with multiple sclerosis risk. Sci. Rep. 10(1), 7327. https:\/\/doi.org\/10.1038\/s41598-020-64432-3 (2020).","journal-title":"Sci. Rep."},{"key":"94053_CR121","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuroscience.2024.12.029","volume":"567","author":"S Rida Zainab","year":"2025","unstructured":"Rida Zainab, S., Zeb Khan, J., Khalid Tipu, M., Jahan, F. & Irshad, N. A review on multiple sclerosis: Unravelling the complexities of pathogenesis, progression, mechanisms and therapeutic innovations. Neuroscience. 567, 133\u2013149. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.12.029 (2025).","journal-title":"Neuroscience."},{"issue":"3","key":"94053_CR122","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3233\/hab-170328","volume":"26","author":"M Mazdeh","year":"2017","unstructured":"Mazdeh, M. et al. Ecotropic Viral Integration Site 5 (EVI5) expression analysis in multiple sclerosis patients. Hum. Antibodies. 26(3), 113\u2013119. https:\/\/doi.org\/10.3233\/hab-170328 (2017).","journal-title":"Hum. Antibodies."},{"key":"94053_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071733","author":"M D\u2019Anca","year":"2021","unstructured":"D\u2019Anca, M. et al. Extracellular vesicles in multiple sclerosis: Role in the pathogenesis and potential usefulness as biomarkers and therapeutic tools. Cells https:\/\/doi.org\/10.3390\/cells10071733 (2021).","journal-title":"Cells"},{"issue":"3","key":"94053_CR124","doi-asserted-by":"publisher","first-page":"103874","DOI":"10.1016\/j.isci.2022.103874","volume":"25","author":"F Liu","year":"2022","unstructured":"Liu, F. et al. Sanguinarine promotes healthspan and innate immunity through a conserved mechanism of ROS-mediated PMK-1\/SKN-1 activation. iScience. 25(3), 103874. https:\/\/doi.org\/10.1016\/j.isci.2022.103874 (2022).","journal-title":"iScience."},{"key":"94053_CR125","doi-asserted-by":"publisher","first-page":"116406","DOI":"10.1016\/j.biopha.2024.116406","volume":"173","author":"LJ Huang","year":"2024","unstructured":"Huang, L. J. et al. Bioactivity and mechanism of action of sanguinarine and its derivatives in the past 10 years. Biomed. Pharmacother. 173, 116406. https:\/\/doi.org\/10.1016\/j.biopha.2024.116406 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"94053_CR126","doi-asserted-by":"publisher","first-page":"1209970","DOI":"10.3389\/fimmu.2023.1209970","volume":"14","author":"H Cai","year":"2023","unstructured":"Cai, H. et al. Protein O-GlcNAcylation in multiple immune cells and its therapeutic potential. Front. Immunol. 14, 1209970. https:\/\/doi.org\/10.3389\/fimmu.2023.1209970 (2023).","journal-title":"Front. Immunol."},{"issue":"7","key":"94053_CR127","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.stemcr.2024.05.009","volume":"19","author":"Q Liu","year":"2024","unstructured":"Liu, Q. et al. O-GlcNAcase regulates pluripotency states of human embryonic stem cells. Stem. Cell Reports. 19(7), 993\u20131009. https:\/\/doi.org\/10.1016\/j.stemcr.2024.05.009 (2024).","journal-title":"Stem. Cell Reports."},{"issue":"2","key":"94053_CR128","doi-asserted-by":"publisher","first-page":"105615","DOI":"10.1016\/j.jbc.2023.105615","volume":"300","author":"ZM Nelson","year":"2024","unstructured":"Nelson, Z. M., Leonard, G. D. & Fehl, C. Tools for investigating O-GlcNAc in signaling and other fundamental biological pathways. J. Biol. Chem. 300(2), 105615. https:\/\/doi.org\/10.1016\/j.jbc.2023.105615 (2024).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"94053_CR129","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13041-022-00906-x","volume":"15","author":"VN Huynh","year":"2022","unstructured":"Huynh, V. N. et al. Acute inhibition of OGA sex-dependently alters the networks associated with bioenergetics, autophagy, and neurodegeneration. Mol. Brain. 15(1), 22. https:\/\/doi.org\/10.1186\/s13041-022-00906-x (2022).","journal-title":"Mol. Brain."},{"issue":"11","key":"94053_CR130","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/s12276-021-00709-5","volume":"53","author":"BE Lee","year":"2021","unstructured":"Lee, B. E., Suh, P. G. & Kim, J. I. O-GlcNAcylation in health and neurodegenerative diseases. Exp. Mol. Med. 53(11), 1674\u20131682. https:\/\/doi.org\/10.1038\/s12276-021-00709-5 (2021).","journal-title":"Exp. Mol. Med."},{"issue":"14","key":"94053_CR131","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1021\/jm010811t","volume":"44","author":"A Carotenuto","year":"2001","unstructured":"Carotenuto, A., D\u2019Ursi, A. M., Nardi, E., Papini, A. M. & Rovero, P. Conformational analysis of a glycosylated human myelin oligodendrocyte glycoprotein peptide epitope able to detect antibody response in multiple sclerosis. J. Med. Chem. 44(14), 2378\u20132381. https:\/\/doi.org\/10.1021\/jm010811t (2001).","journal-title":"J. Med. Chem."},{"key":"94053_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmcr.2024.100195","author":"A Sharma","year":"2024","unstructured":"Sharma, A., Singh, A., Debnath, R., Gupta, G. D. & Sharma, K. Role of O-GlcNAcylation in Alzheimer\u2019s Disease: Insights and Perspectives. Eur. J. Med. Chem. Rep. https:\/\/doi.org\/10.1016\/j.ejmcr.2024.100195 (2024).","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"94053_CR133","doi-asserted-by":"publisher","first-page":"871535","DOI":"10.3389\/fnhum.2022.871535","volume":"16","author":"SM Ostojic","year":"2022","unstructured":"Ostojic, S. M. Guanidinoacetic Acid as a Nutritional Adjuvant to Multiple Sclerosis Therapy. Front. Hum. Neurosci. 16, 871535. https:\/\/doi.org\/10.3389\/fnhum.2022.871535 (2022).","journal-title":"Front. Hum. Neurosci."},{"issue":"12","key":"94053_CR134","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1021\/ml500450c","volume":"5","author":"AF Abdel-Magid","year":"2014","unstructured":"Abdel-Magid, A. F. Inhibition of O-GlcNAcase (OGA): A Potential Therapeutic Target to Treat Alzheimer\u2019s Disease. ACS Med. Chem. Lett. 5(12), 1270\u20131271. https:\/\/doi.org\/10.1021\/ml500450c (2014).","journal-title":"ACS Med. Chem. Lett."},{"issue":"12","key":"94053_CR135","doi-asserted-by":"publisher","first-page":"105411","DOI":"10.1016\/j.jbc.2023.105411","volume":"299","author":"MR Pratt","year":"2023","unstructured":"Pratt, M. R. & Vocadlo, D. J. Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseases. J. Biol. Chem. 299(12), 105411. https:\/\/doi.org\/10.1016\/j.jbc.2023.105411 (2023).","journal-title":"J. Biol. Chem."},{"issue":"3","key":"94053_CR136","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1212\/wnl.58.3.446","volume":"58","author":"PJ Lindsberg","year":"2002","unstructured":"Lindsberg, P. J. et al. Release of soluble ICAM-5, a neuronal adhesion molecule, in acute encephalitis. Neurology. 58(3), 446\u2013451. https:\/\/doi.org\/10.1212\/wnl.58.3.446 (2002).","journal-title":"Neurology."},{"issue":"7","key":"94053_CR137","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1182\/blood-2007-09-111179","volume":"111","author":"L Tian","year":"2008","unstructured":"Tian, L. et al. Shedded neuronal ICAM-5 suppresses T-cell activation. Blood 111(7), 3615\u20133625. https:\/\/doi.org\/10.1182\/blood-2007-09-111179 (2008).","journal-title":"Blood"},{"key":"94053_CR138","doi-asserted-by":"publisher","first-page":"368938","DOI":"10.1155\/2012\/368938","volume":"2012","author":"H Yang","year":"2012","unstructured":"Yang, H. Structure, Expression, and Function of ICAM-5. Comp Funct Genomics. 2012, 368938. https:\/\/doi.org\/10.1155\/2012\/368938 (2012).","journal-title":"Comp Funct Genomics."},{"issue":"6","key":"94053_CR139","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.oraloncology.2005.01.002","volume":"41","author":"SI Maruya","year":"2005","unstructured":"Maruya, S. I. et al. ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion!. Oral. Oncol. 41(6), 580\u2013588. https:\/\/doi.org\/10.1016\/j.oraloncology.2005.01.002 (2005).","journal-title":"Oral. Oncol."},{"key":"94053_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051219","author":"Y Teng","year":"2021","unstructured":"Teng, Y. et al. The PI3K\/Akt Pathway: Emerging Roles in Skin Homeostasis and a Group of Non-Malignant Skin Disorders. Cells https:\/\/doi.org\/10.3390\/cells10051219 (2021).","journal-title":"Cells"},{"issue":"4","key":"94053_CR141","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jaad.2015.07.002","volume":"73","author":"I Landells","year":"2015","unstructured":"Landells, I. et al. Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study. J. Am. Acad. Dermatol. 73(4), 594\u2013603. https:\/\/doi.org\/10.1016\/j.jaad.2015.07.002 (2015).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"94053_CR142","doi-asserted-by":"publisher","first-page":"e15180","DOI":"10.1111\/exd.15180","volume":"33","author":"SS Rane","year":"2024","unstructured":"Rane, S. S., Shellard, E., Adamson, A., Eyre, S. & Warren, R. B. IL23R mutations associated with decreased risk of psoriasis lead to the differential expression of genes implicated in the disease. Exp. Dermatol. 33(9), e15180. https:\/\/doi.org\/10.1111\/exd.15180 (2024).","journal-title":"Exp. Dermatol."},{"issue":"7","key":"94053_CR143","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.42099","volume":"74","author":"G Chen","year":"2022","unstructured":"Chen, G. et al. Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis. Arthritis Rheumatol. 74(7), 1271\u20131283. https:\/\/doi.org\/10.1002\/art.42099 (2022).","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"94053_CR144","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/toxsci\/kfv235","volume":"149","author":"B Xu","year":"2016","unstructured":"Xu, B. et al. 2,3\u2019,4,4\u2019,5-Pentachlorobiphenyl Induces Inflammatory Responses in the Thyroid Through JNK and Aryl Hydrocarbon Receptor-Mediated Pathway. Toxicol. Sci. 149(2), 300\u2013311. https:\/\/doi.org\/10.1093\/toxsci\/kfv235 (2016).","journal-title":"Toxicol. Sci."},{"issue":"7","key":"94053_CR145","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1177\/0192623312443320","volume":"40","author":"HS Strauss","year":"2012","unstructured":"Strauss, H. S. & Heiger-Bernays, W. Methodological limitations may prevent the observation of non-Hodgkin\u2019s lymphoma in bioassays of polychlorinated biphenyls. Toxicol. Pathol. 40(7), 995\u20131003. https:\/\/doi.org\/10.1177\/0192623312443320 (2012).","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"94053_CR146","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/toxsci\/kfac044","volume":"188","author":"N Aluru","year":"2022","unstructured":"Aluru, N. & Engelhardt, J. Exposure to 3,3\u2019,4,4\u2019,5-Pentachlorobiphenyl (PCB126) Causes Widespread DNA Hypomethylation in Adult Zebrafish Testis. Toxicol. Sci. 188(1), 75\u201387. https:\/\/doi.org\/10.1093\/toxsci\/kfac044 (2022).","journal-title":"Toxicol. Sci."},{"key":"94053_CR147","doi-asserted-by":"publisher","first-page":"1274539","DOI":"10.3389\/fimmu.2023.1274539","volume":"14","author":"MM Angioni","year":"2023","unstructured":"Angioni, M. M. et al. Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: A gene expression study. Front. Immunol. 14, 1274539. https:\/\/doi.org\/10.3389\/fimmu.2023.1274539 (2023).","journal-title":"Front. Immunol."},{"issue":"12","key":"94053_CR148","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1038\/s41423-021-00777-7","volume":"18","author":"P Hou","year":"2021","unstructured":"Hou, P. et al. Correction: Autophagy receptor CCDC50 modulates STING-mediated interferon response in viral infection and autoimmune disease. Cell Mol. Immunol. 18(12), 2682. https:\/\/doi.org\/10.1038\/s41423-021-00777-7 (2021).","journal-title":"Cell Mol. Immunol."},{"issue":"1","key":"94053_CR149","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41422-020-0362-1","volume":"31","author":"P Hou","year":"2021","unstructured":"Hou, P. et al. A novel selective autophagy receptor, CCDC50, delivers K63 polyubiquitination-activated RIG-I\/MDA5 for degradation during viral infection. Cell Res. 31(1), 62\u201379. https:\/\/doi.org\/10.1038\/s41422-020-0362-1 (2021).","journal-title":"Cell Res."},{"key":"94053_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147354","author":"S Blunder","year":"2021","unstructured":"Blunder, S., Pavel, P., Minzaghi, D. & Dubrac, S. PPARdelta in affected atopic dermatitis and psoriasis: A possible role in metabolic reprograming. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22147354 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"94053_CR151","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/15548627.2022.2080957","volume":"19","author":"P Hou","year":"2023","unstructured":"Hou, P. et al. The regulation of NLRP3 inflammasome activation by CCDC50-mediated autophagy. Autophagy. 19(1), 365\u2013366. https:\/\/doi.org\/10.1080\/15548627.2022.2080957 (2023).","journal-title":"Autophagy."},{"issue":"10","key":"94053_CR152","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/1756-185x.13879","volume":"23","author":"J Chen","year":"2020","unstructured":"Chen, J., Yuan, F., Fan, X. & Wang, Y. Psoriatic arthritis: A systematic review of non-HLA genetic studies and important signaling pathways. Int. J. Rheum. Dis. 23(10), 1288\u20131296. https:\/\/doi.org\/10.1111\/1756-185x.13879 (2020).","journal-title":"Int. J. Rheum. Dis."},{"issue":"5","key":"94053_CR153","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/j.1365-2133.2009.09102.x","volume":"160","author":"JP McFadden","year":"2009","unstructured":"McFadden, J. P., Baker, B. S., Powles, A. V. & Fry, L. Psoriasis and streptococci: The natural selection of psoriasis revisited. Br. J. Dermatol. 160(5), 929\u2013937. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09102.x (2009).","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"94053_CR154","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1007\/s13277-015-3531-y","volume":"37","author":"Y Jiang","year":"2016","unstructured":"Jiang, Y. et al. Methyl methanesulfonate induces necroptosis in human lung adenoma A549 cells through the PIG-3-reactive oxygen species pathway. Tumour. Biol. 37(3), 3785\u20133795. https:\/\/doi.org\/10.1007\/s13277-015-3531-y (2016).","journal-title":"Tumour. Biol."},{"issue":"Pt 1","key":"94053_CR155","doi-asserted-by":"publisher","first-page":"131743","DOI":"10.1016\/j.ijbiomac.2024.131743","volume":"268","author":"M Mustafa","year":"2024","unstructured":"Mustafa, M. et al. Characterization of structural, genotoxic, and immunological effects of methyl methanesulfonate (MMS) induced DNA modifications: Implications for inflammation-driven carcinogenesis. Int. J. Biol. Macromol. 268(Pt 1), 131743. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131743 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"94053_CR156","doi-asserted-by":"publisher","first-page":"6669","DOI":"10.1038\/ncomms7669","volume":"6","author":"M Mellett","year":"2015","unstructured":"Mellett, M. et al. Orphan receptor IL-17RD regulates Toll-like receptor signalling via SEFIR\/TIR interactions. Nat. Commun. 6, 6669. https:\/\/doi.org\/10.1038\/ncomms7669 (2015).","journal-title":"Nat. Commun."},{"issue":"1","key":"94053_CR157","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12964-020-00695-7","volume":"19","author":"S Pande","year":"2021","unstructured":"Pande, S., Yang, X. & Friesel, R. Interleukin-17 receptor D (Sef) is a multi-functional regulator of cell signaling. Cell Commun. Signal. 19(1), 6. https:\/\/doi.org\/10.1186\/s12964-020-00695-7 (2021).","journal-title":"Cell Commun. Signal."},{"key":"94053_CR158","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/ncomms2127","volume":"3","author":"M Mellett","year":"2012","unstructured":"Mellett, M. et al. Orphan receptor IL-17RD tunes IL-17A signalling and is required for neutrophilia. Nat. Commun. 3, 1119. https:\/\/doi.org\/10.1038\/ncomms2127 (2012).","journal-title":"Nat. Commun."},{"issue":"8","key":"94053_CR159","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","volume":"9","author":"SL Gaffen","year":"2009","unstructured":"Gaffen, S. L. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9(8), 556\u2013567. https:\/\/doi.org\/10.1038\/nri2586 (2009).","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"94053_CR160","doi-asserted-by":"publisher","first-page":"256","DOI":"10.5114\/pdia.2014.40954","volume":"31","author":"AG Shabgah","year":"2014","unstructured":"Shabgah, A. G., Fattahi, E. & Shahneh, F. Z. Interleukin-17 in human inflammatory diseases. Postepy. Dermatol. Alergol. 31(4), 256\u2013261. https:\/\/doi.org\/10.5114\/pdia.2014.40954 (2014).","journal-title":"Postepy. Dermatol. Alergol."},{"issue":"1","key":"94053_CR161","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s13238-011-1006-5","volume":"2","author":"X Zhang","year":"2011","unstructured":"Zhang, X., Angkasekwinai, P., Dong, C. & Tang, H. Structure and function of interleukin-17 family cytokines. Protein Cell. 2(1), 26\u201340. https:\/\/doi.org\/10.1007\/s13238-011-1006-5 (2011).","journal-title":"Protein Cell."},{"issue":"4\u20135","key":"94053_CR162","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.autrev.2014.01.050","volume":"13","author":"E Suzuki","year":"2014","unstructured":"Suzuki, E., Mellins, E. D., Gershwin, M. E., Nestle, F. O. & Adamopoulos, I. E. The IL-23\/IL-17 axis in psoriatic arthritis. Autoimmun. Rev. 13(4\u20135), 496\u2013502. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.050 (2014).","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"94053_CR163","doi-asserted-by":"publisher","first-page":"6268","DOI":"10.1038\/s41467-023-41984-2","volume":"14","author":"Q Xiao","year":"2023","unstructured":"Xiao, Q. et al. Immunosuppression causes dynamic changes in expression QTLs in psoriatic skin. Nat. Commun. 14(1), 6268. https:\/\/doi.org\/10.1038\/s41467-023-41984-2 (2023).","journal-title":"Nat. Commun."},{"key":"94053_CR164","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021042","author":"L Rusi\u00f1ol","year":"2024","unstructured":"Rusi\u00f1ol, L. & Puig, L. Multi-omics approach to improved diagnosis and treatment of atopic dermatitis and psoriasis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms25021042 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"94053_CR165","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12016-012-8307-1","volume":"44","author":"SP Raychaudhuri","year":"2013","unstructured":"Raychaudhuri, S. P. Role of IL-17 in psoriasis and psoriatic arthritis. Clin. Rev. Allergy Immunol. 44(2), 183\u2013193. https:\/\/doi.org\/10.1007\/s12016-012-8307-1 (2013).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"94053_CR166","doi-asserted-by":"publisher","first-page":"106254","DOI":"10.1016\/j.jsbmb.2023.106254","volume":"229","author":"K Motomura","year":"2023","unstructured":"Motomura, K. et al. The effects of progesterone on immune cellular function at the maternal-fetal interface and in maternal circulation. J. Steroid Biochem. Mol. Biol. 229, 106254. https:\/\/doi.org\/10.1016\/j.jsbmb.2023.106254 (2023).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"94053_CR167","doi-asserted-by":"publisher","first-page":"672168","DOI":"10.3389\/fimmu.2021.672168","volume":"12","author":"S Hellberg","year":"2021","unstructured":"Hellberg, S. et al. Progesterone Dampens Immune Responses in In Vitro Activated CD4(+) T Cells and Affects Genes Associated With Autoimmune Diseases That Improve During Pregnancy. Front. Immunol. 12, 672168. https:\/\/doi.org\/10.3389\/fimmu.2021.672168 (2021).","journal-title":"Front. Immunol."},{"issue":"5","key":"94053_CR168","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/mi.2017.35","volume":"10","author":"OJ Hall","year":"2017","unstructured":"Hall, O. J. & Klein, S. L. Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites. Mucosal. Immunol. 10(5), 1097\u20131107. https:\/\/doi.org\/10.1038\/mi.2017.35 (2017).","journal-title":"Mucosal. Immunol."},{"issue":"1","key":"94053_CR169","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00404-023-06996-9","volume":"309","author":"M Zwahlen","year":"2024","unstructured":"Zwahlen, M. & Stute, P. Impact of progesterone on the immune system in women: A systematic literature review. Arch. Gynecol. Obstet. 309(1), 37\u201346. https:\/\/doi.org\/10.1007\/s00404-023-06996-9 (2024).","journal-title":"Arch. Gynecol. Obstet."},{"issue":"46","key":"94053_CR170","doi-asserted-by":"publisher","first-page":"18649","DOI":"10.1073\/pnas.1113170108","volume":"108","author":"X Guo","year":"2011","unstructured":"Guo, X. et al. UBLCP1 is a 26S proteasome phosphatase that regulates nuclear proteasome activity. Proc. Natl. Acad. Sci. U S A. 108(46), 18649\u201318654. https:\/\/doi.org\/10.1073\/pnas.1113170108 (2011).","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"1","key":"94053_CR171","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41398-023-02702-0","volume":"13","author":"J Soueid","year":"2023","unstructured":"Soueid, J., Hamze, Z., Bedran, J., Chahrour, M. & Boustany, R. M. A novel autism-associated UBLCP1 mutation impacts proteasome regulation\/activity. Transl. Psychiatry. 13(1), 404. https:\/\/doi.org\/10.1038\/s41398-023-02702-0 (2023).","journal-title":"Transl. Psychiatry."},{"key":"94053_CR172","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.170042","author":"S Sun","year":"2017","unstructured":"Sun, S. et al. Phosphatase UBLCP1 controls proteasome assembly. Open Biol. https:\/\/doi.org\/10.1098\/rsob.170042 (2017).","journal-title":"Open Biol."},{"issue":"1","key":"94053_CR173","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.1038\/s41467-023-43262-7","volume":"14","author":"LC Hunt","year":"2023","unstructured":"Hunt, L. C. et al. An adaptive stress response that confers cellular resilience to decreased ubiquitination. Nat. Commun. 14(1), 7348. https:\/\/doi.org\/10.1038\/s41467-023-43262-7 (2023).","journal-title":"Nat. Commun."},{"issue":"2","key":"94053_CR174","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1167\/iovs.17-23247","volume":"59","author":"Y Yue","year":"2018","unstructured":"Yue, Y. et al. Association of Long Noncoding RNAs Polymorphisms With Ankylosing Spondylitis, Vogt-Koyanagi-Harada Disease, and Behcet\u2019s Disease. Invest. Ophthalmol. Vis. Sci. 59(2), 1158\u20131166. https:\/\/doi.org\/10.1167\/iovs.17-23247 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"94053_CR175","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/hmg\/ddab237","volume":"31","author":"D Zhu","year":"2021","unstructured":"Zhu, D. et al. A transcriptome-wide association study identifies novel susceptibility genes for psoriasis. Hum. Mol. Genet. 31(2), 300\u2013308. https:\/\/doi.org\/10.1093\/hmg\/ddab237 (2021).","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"94053_CR176","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.jid.2019.03.1157","volume":"139","author":"Q Zhen","year":"2019","unstructured":"Zhen, Q. et al. Genetic Study on Small Insertions and Deletions in Psoriasis Reveals a Role in Complex Human Diseases. J. Invest. Dermatol. 139(11), 2302\u201312.e14. https:\/\/doi.org\/10.1016\/j.jid.2019.03.1157 (2019).","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"94053_CR177","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/24755303211026023","volume":"6","author":"A Bui","year":"2021","unstructured":"Bui, A. et al. Identifying Novel Psoriatic Disease Drug Targets Using a Genetics-Based Priority Index Pipeline. J. Psoriasis Psoriatic Arthritis. 6(4), 185\u2013197. https:\/\/doi.org\/10.1177\/24755303211026023 (2021).","journal-title":"J. Psoriasis Psoriatic Arthritis."},{"issue":"1","key":"94053_CR178","doi-asserted-by":"publisher","first-page":"2302046","DOI":"10.1080\/15502783.2024.2302046","volume":"21","author":"BM Roberts","year":"2024","unstructured":"Roberts, B. M., Geddis, A. V. & Matheny, R. W. Jr. The dose-response effects of flurbiprofen, indomethacin, ibuprofen, and naproxen on primary skeletal muscle cells. J. Int. Soc. Sports Nutr. 21(1), 2302046. https:\/\/doi.org\/10.1080\/15502783.2024.2302046 (2024).","journal-title":"J. Int. Soc. Sports Nutr."},{"key":"94053_CR179","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjae015","author":"M Wang","year":"2024","unstructured":"Wang, M. et al. Indomethacin restrains cytoplasmic nucleic acid-stimulated immune responses by inhibiting the nuclear translocation of IRF3. J. Mol. Cell Biol. https:\/\/doi.org\/10.1093\/jmcb\/mjae015 (2024).","journal-title":"J. Mol. Cell Biol."},{"issue":"9","key":"94053_CR180","doi-asserted-by":"publisher","first-page":"107631","DOI":"10.1016\/j.isci.2023.107631","volume":"26","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response. iScience. 26(9), 107631. https:\/\/doi.org\/10.1016\/j.isci.2023.107631 (2023).","journal-title":"iScience."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94053-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94053-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94053-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:37:13Z","timestamp":1743122233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94053-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":180,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94053"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94053-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that this study was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this study, all of our GWAS data were sourced from already published statistical data, so there was no need for us to seek additional ethical approval.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"10618"}}